Foscarnet Sodium
- Product NDC
- 65145-191
- 11-digit product format
- 651450191
- Labeler code
- 65145
- Product ID
- 65145-191_6ec3bb2a-fb40-4d4a-bc1b-feea80cc1a95
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Foscarnet Sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Caplin Steriles Limited
- Application
- ANDA220068
- Marketing category
- ANDA
- Marketing start
- 2026-05-20
- Substance
- FOSCARNET SODIUM
- Active strength
- 24 mg/mL
- Pharmacologic classes
- Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Foscarnet Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FOSCARNET SODIUM | 24 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 964YS0OOG1 |
| Rxcui | 1734377 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65145-191-01 | Foscarnet Sodium | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | | 1 |
| 65145-191-01 | Foscarnet Sodium | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | | 1 |
| 65145-191-10 | Foscarnet Sodium | 10 in 1 CASE | INJECTION, SOLUTION | 10 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 65145-191-01 | 65145019101 | 250 mL in 1 BAG | 250 ml | | | | Historical |
| 65145-191-10 | 65145019110 | 10 POUCH in 1 CASE (65145-191-10) / 1 BAG in 1 POUCH (65145-191-01) / 250 mL in 1 BAG | 10 pouch | 2026-05-20 | No | No | Historical |